ea0037ep711 | Pituitary: basic and neuroendocrinology | ECE2015
Haviv Asi
, Kramer Susan
, Patou Gary
, Tillotson Gary
Introduction: Injectable somatostatin analogues (SRLs) are the standard medical management of acromegaly. Injection site adverse reactions reported for parenteral SRLs were examined in the literature and in the FDA Adverse Events Reporting System (AERS), and compared to the respective drug labels.Methods: PubMed was searched using criteria: period 19952013, drugs octreotide (Sandostatin®), lanreotide (Somatuline®</s...